On Sep 7, 2021 Owlstone Medical closed a Series D round and raised £42,000,000 from Horizons Ventures, featuring lead investors Horizons Ventures.

About the company: Owlstone Medical is located at United Kingdom, Europe.
“A breathalyzer for disease. Breath Biopsy: The leader in non-invasive breath biomarker research. Our mission: Save 100,000 lives and $1.5B healthcare costs.”

Company website: http://www.owlstonemedical.com